$0.00▾ 71.43%
End-of-day close · 2026-07-21
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$-48.71MTTM operating cash
Pre-profit
It is still burning cash while pre-profit.
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
+11.4%year over year
Decelerating
Growth is positive but slowing.
Leverage
Lowdebt to assets
Healthy
A modest, well-covered debt load.
More coming: dilution / share-count creep.
✦ The read
GeneDx Holdings Corp. is pre-profit. It is still burning cash while pre-profit. Growth is positive but slowing. A modest, well-covered debt load.
Key numbers
Valuation
EPS (TTM)$-3.64
TTM (trailing 12 months, through fiscal Q2 FY2026)
Profitability
Net margin-23.4%
TTM (trailing 12 months, through fiscal Q2 FY2026)
Size
Revenue (TTM)$454.43M
TTM (trailing 12 months, through fiscal Q2 FY2026)
Recent news
Sentiment · last 30 days18 articles
0 bullish0 neutral18 bearish
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines – WGS
WGS DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm
Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm
Signals and key numbers are from the fiscal Q2 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.